Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) as a Neoadjuvant Chemotherapy for Non-metastatic Esophageal Cancer (nMEC)

Objective: Perioperative chemotherapy can potentially downstage esophageal cancer, reducing the risk of early systemic dissemination. One recommended neoadjuvant regimen for managing gastroesophageal junction and esophageal cancer is docetaxel, cisplatin, and 5-fluorouracil (DCF). To address the hig...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Med Res
Main Authors: Onitilo, Adedayo A., Stankowski-Drengler, Trista J., Shiyanbola, Oyewale, Engel, Jessica, Tanimu, Sabo, Fagbemi, Seth O., Li, Ya-Huei
Formato: Artigo
Idioma:Inglês
Publicado: Marshfield Clinic 2021
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8231693/
https://ncbi.nlm.nih.gov/pubmed/33789952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.2021.1573
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares